2026-2027 | Live Session | Hallucinogen Use Disorders, and Psychedelics for the Treatment of Substance Use Disorders | February 2027
Availability
Registration Required
Online Meeting
Feb 03, 2027 1:00 PM - 3:00 PM CT
Cost
$0.00
Included with ACAAM membership. Join ACAAM to access this and other educational offerings.

ACAAM Members, select "Get Started" to register for this session.

This live session provides a focused overview of hallucinogen use and related disorders in addiction medicine, emphasizing the clinical effects, risks, and emerging therapeutic applications of psychedelics and other hallucinogenic substances.

What This Includes

• Epidemiology, classification, and pharmacology of psychedelics and other hallucinogenic substances
• Patterns of use across a range of hallucinogens
• Clinical presentations associated with hallucinogen use, including intoxication and persistent perceptual changes
• Hallucinogen-induced psychiatric conditions and related diagnostic considerations
• Evaluation of risks and clinical challenges associated with hallucinogen use
• Emerging evidence regarding the potential therapeutic use of psychedelics in substance use disorders
• Clinical frameworks for assessing both risks and therapeutic potential in practice

What to Expect

• Live, faculty-led instruction delivered in an interactive online format
• Discussion of current trends, clinical challenges, and emerging research related to hallucinogens and psychedelics
• Structured content aligned with the ACAAM National Addiction Medicine Didactic Curriculum and ABPM content areas
• Case-based examples illustrating assessment, diagnosis, and management considerations
• Practical guidance for evaluating hallucinogen-related presentations and emerging therapeutic applications in addiction medicine practice

Suzuki, Joji | Pri-Med

Joji Suzuki, MD

Dr. Suzuki is Director of the Division of Addiction Psychiatry at Brigham and Women’s Hospital and Program Director of the Addiction Medicine Fellowship. He is an Assistant Professor of Psychiatry at Harvard Medical School.

His work focuses on addiction psychiatry, substance use disorders, and medical psychiatry, with an emphasis on clinical research and medical education. He has received federal research funding and has published extensively in addiction and psychiatric care.

The session recording will be made available in the corresponding On-Demand course after processing. Access the recording through the On-Demand section of the ACAAM Learning Portal.

To support a meaningful learning experience and recognize your participation:

  • After viewing a minimum of [60] minutes of the session, the evaluation will become available
  • We encourage you to complete the evaluation to reflect on the content and provide valuable feedback
  • Upon completion, a Certificate of Participation will be issued for your records
Powered By